Literature DB >> 16177108

A novel role of CD30/CD30 ligand signaling in the generation of long-lived memory CD8+ T cells.

Hitoshi Nishimura1, Toshiki Yajima, Hiromi Muta, Eckhard R Podack, Kenzaburo Tani, Yasunobu Yoshikai.   

Abstract

Memory CD8+ T cells can be divided into two subsets, central memory (T(CM)) and effector memory (T(EM)) CD8+ T cells. We found that CD30, a member of the TNFR-associated factor (TRAF)-linked TNFR superfamily, signaling is involved in differentiation of long-lived CD8+ T(CM) cells following Listeria monocytogenes infection. Although CD8+ T(EM) cells transiently accumulated in the nonlymphoid tissues of CD30 ligand (CD153-/-) mice after infection, long-lived memory CD8+ T(CM) cells were poorly generated in these mice. CCR7 mRNA expression was down-regulated in CD8+ T cells of the spleen of CD153-/- mice in vivo and the expression was up-regulated in CD8+ T(EM) cells by anti-CD30 mAb cross-linking in vitro. These results suggest that CD30/CD30 ligand signaling plays an important role in the generation of long-lived memory CD8+ T cells at least partly by triggering homing receptors for T(CM) cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177108     DOI: 10.4049/jimmunol.175.7.4627

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Deciphering CD30 ligand biology and its role in humoral immunity.

Authors:  Mary K Kennedy; Cynthia R Willis; Richard J Armitage
Journal:  Immunology       Date:  2006-06       Impact factor: 7.397

2.  The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness.

Authors:  Tuoqi Wu; Yun Ji; E Ashley Moseman; Haifeng C Xu; Monica Manglani; Martha Kirby; Stacie M Anderson; Robin Handon; Elizabeth Kenyon; Abdel Elkahloun; Weiwei Wu; Philipp A Lang; Luca Gattinoni; Dorian B McGavern; Pamela L Schwartzberg
Journal:  Sci Immunol       Date:  2016-12-09

Review 3.  Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity.

Authors:  Shahram Salek-Ardakani; Michael Croft
Journal:  J Interferon Cytokine Res       Date:  2010-04       Impact factor: 2.607

4.  CD30 ligand/CD30 interaction is involved in pathogenesis of inflammatory bowel disease.

Authors:  Shinichi Somada; Hiromi Muta; Kazuhiko Nakamura; Xun Sun; Kuniomi Honda; Eikichi Ihara; Hirotada Akiho; Ryoichi Takayanagi; Yasunobu Yoshikai; Eckhard R Podack; Kenzaburo Tani
Journal:  Dig Dis Sci       Date:  2012-03-27       Impact factor: 3.199

5.  Tcf1-CTCF cooperativity shapes genomic architecture to promote CD8+ T cell homeostasis.

Authors:  Qiang Shan; Shaoqi Zhu; Xia Chen; Jia Liu; Shuang Yuan; Xiang Li; Weiqun Peng; Hai-Hui Xue
Journal:  Nat Immunol       Date:  2022-07-26       Impact factor: 31.250

Review 6.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

Review 7.  The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses.

Authors:  Lindsay K Ward-Kavanagh; Wai Wai Lin; John R Šedý; Carl F Ware
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

Review 8.  CD30: from basic research to cancer therapy.

Authors:  Hiromi Muta; Eckhard R Podack
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

9.  Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens.

Authors:  Michael J Zilliox; Giovanni Parmigiani; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.

Authors:  Ali Alejo; Margarida Saraiva; Maria Begoña Ruiz-Argüello; Abel Viejo-Borbolla; Mar Fernández de Marco; Francisco Javier Salguero; Antonio Alcami
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.